a
a
Weather:
No weather information available
HomeHealthBreakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

SAN DIEGO, March 2, 2025 /PRNewswire/ — Longbio Pharma (Suzhou) Co., Ltd. (referred to as “Longbio”), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other autoimmune and rare diseases,…

No comments

Sorry, the comment form is closed at this time.

Translate »